Lexeo Therapeutics | 4:持股變動聲明-高管 Otero Jose Manuel
Lexeo Therapeutics | 4:持股變動聲明-高管 Robertson Jenny
Lexeo Therapeutics | 4:持股變動聲明-高管 See Tai Sandi
Lexeo Therapeutics | 4:持股變動聲明-高管 Townsend Richard Nolan
Lexeo Therapeutics | 4:持股變動聲明-高管 Robertson Jenny
Lexeo Therapeutics | 4:持股變動聲明-高管 Adler Eric
Lexeo Therapeutics | 4:持股變動聲明-高管 See Tai Sandi
Lexeo Therapeutics | 4:持股變動聲明-高管 Townsend Richard Nolan
Lexeo Therapeutics | 4:持股變動聲明-高管 Rasbach Kyle
Lexeo Therapeutics | 4:持股變動聲明-高管 Adler Eric
Lexeo Therapeutics | 4:持股變動聲明-高管 See Tai Sandi
Lexeo Therapeutics | 4:持股變動聲明-高管 Robertson Jenny
Lexeo Therapeutics | 4:持股變動聲明-高管 Otero Jose Manuel
Lexeo Therapeutics | 4:持股變動聲明-高管 Townsend Richard Nolan
Lexeo Therapeutics | 3:首次持股聲明-高管 Rasbach Kyle
Lexeo Therapeutics | 4:持股變動聲明-高管 Townsend Richard Nolan
Lexeo Therapeutics | 4:持股變動聲明-董事 CHOLMONDELEY PAULA H
Lexeo Therapeutics | SC 13G/A:超過5%持股股東披露文件(修正)-Lundbeckfond Invest A/S(2.9%),Lene Skole(2.9%)
Lexeo Therapeutics | SC 13G/A:超過5%持股股東披露文件(修正)-Longitude Capital Partners IV, LLC(8.4%),Longitude Venture Partners IV, L.P.(8.4%)等
Lexeo Therapeutics | SC 13G/A:超過5%持股股東披露文件(修正)-Janus Henderson Group plc(11.4%),Janus Henderson Biotech Innovation Master Fund Ltd(5.7%)